Back to search
FDAFDA · Food and drugs·Recall number D-0008-2017

PredniSONE Tablets USP, 1 mg, 100-count bottles, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-4741-25.

Published October 12, 2016 · Recall initiated: October 3, 2016

Summary

FDA records drug Class II recall D-0008-2017, published October 12, 2016 and initiated October 3, 2016. Recalling firm: West-Ward Pharmaceutical; Status: Terminated; Reported quantity: 15,109 bottles; Lot: Lot # 660621A, Exp 01/31/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.

What to do

Voluntary: Firm initiated · Letter

Get an email if PREDNISONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PREDNISONE
Manufacturer
West-Ward Pharmaceutical
Distributor
US Nationwide.
UPC
0300543722507
Lot
Lot # 660621A, Exp 01/31/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PredniSONE Tablets USP, 1 mg, 100-count bottles, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-4741-25. recalled?

Yes. FDA published recall D-0008-2017 on October 12, 2016. Reported hazard: Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PREDNISONE. UPC: 0300543722507.